Literature DB >> 25170317

Topiramate, zonisamide and small for gestational age: maternal factors, timing of exposure and baby fat.

Cynthia L Harden.   

Abstract

Entities:  

Year:  2014        PMID： 25170317      PMCID： PMC4120389          DOI： 10.5698/1535-7597-14.4.199

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  8 in total

1.  Effects of topiramate use on body composition and resting metabolic rate in migraine patients.

Authors:  Mehmet Yaman; Kagan Ucok; Hayri Demirbas; Abdurrahman Genc; Serdar Oruc; Hatice Karabacak; Gokhan Koyuncu
Journal:  Neurol Sci       Date:  2012-03-06       Impact factor: 3.307

2.  Affect of seizures during gestation on pregnancy outcomes in women with epilepsy.

Authors:  Yi-Hua Chen; Hung-Yi Chiou; Herng-Ching Lin; Hsiu-Li Lin
Journal:  Arch Neurol       Date:  2009-08

3.  Comparative safety of antiepileptic drugs during pregnancy.

Authors:  S Hernández-Díaz; C R Smith; A Shen; R Mittendorf; W A Hauser; M Yerby; L B Holmes
Journal:  Neurology       Date:  2012-05-02       Impact factor: 9.910

4.  Association between topiramate and zonisamide use during pregnancy and low birth weight.

Authors:  Sonia Hernández-Díaz; Robert Mittendorf; Caitlin R Smith; W Allen Hauser; Mark Yerby; Lewis B Holmes
Journal:  Obstet Gynecol       Date:  2014-01       Impact factor: 7.661

Review 5.  Outcomes of maternal weight gain.

Authors:  Meera Viswanathan; Anna Maria Siega-Riz; Merry K Moos; Andrea Deierlein; Sunni Mumford; Julie Knaack; Patricia Thieda; Linda J Lux; Kathleen N Lohr
Journal:  Evid Rep Technol Assess (Full Rep)       Date:  2008-05

6.  Use of topiramate in pregnancy and risk of oral clefts.

Authors:  Andrea V Margulis; Allen A Mitchell; Suzanne M Gilboa; Martha M Werler; Murray A Mittleman; Robert J Glynn; Sonia Hernandez-Diaz
Journal:  Am J Obstet Gynecol       Date:  2012-07-16       Impact factor: 8.661

Review 7.  Management issues for women with epilepsy-Focus on pregnancy (an evidence-based review): II. Teratogenesis and perinatal outcomes: Report of the Quality Standards Subcommittee and Therapeutics and Technology Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

Authors:  Cynthia L Harden; Kimford J Meador; Page B Pennell; W Allen Hauser; Gary S Gronseth; Jacqueline A French; Samuel Wiebe; David Thurman; Barbara S Koppel; Peter W Kaplan; Julian N Robinson; Jennifer Hopp; Tricia Y Ting; Barry Gidal; Collin A Hovinga; Andrew N Wilner; Blanca Vazquez; Lewis Holmes; Allan Krumholz; Richard Finnell; Deborah Hirtz; Claire Le Guen
Journal:  Epilepsia       Date:  2009-05       Impact factor: 5.864

8.  Topiramate use in pregnancy and the birth prevalence of oral clefts.

Authors:  Daniel Mines; Patricia Tennis; Suellen M Curkendall; De-Kun Li; Craig Peterson; Elizabeth B Andrews; Brian Calingaert; Hong Chen; Gaurav Deshpande; Daina B Esposito; Nicholas Everage; Crystal N Holick; Nicole M Meyer; Ella T Nkhoma; Sherry Quinn; Kenneth J Rothman; K Arnold Chan
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-04-01       Impact factor: 2.890
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.